China · Delayed Price · Currency is CNY Cisen Pharmaceutical Statistics
Total Valuation
SHA:603367 has a market cap or net worth of CNY 6.47 billion. The enterprise value is 2.89 billion.
| Market Cap | 6.47B |
| Enterprise Value | 2.89B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Jun 3, 2026 |
Share Statistics
SHA:603367 has 452.75 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Current Share Class | 452.75M |
| Shares Outstanding | 452.75M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +2.25% |
| Owned by Insiders (%) | 6.63% |
| Owned by Institutions (%) | 4.54% |
| Float | 205.06M |
Valuation Ratios
The trailing PE ratio is 14.28.
| PE Ratio | 14.28 |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | 12.66 |
| P/OCF Ratio | 11.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.80, with an EV/FCF ratio of 5.66.
| EV / Earnings | 6.33 |
| EV / Sales | 0.85 |
| EV / EBITDA | 5.80 |
| EV / EBIT | 10.20 |
| EV / FCF | 5.66 |
Financial Position
The company has a current ratio of 4.53, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.53 |
| Quick Ratio | 3.64 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.06 |
| Interest Coverage | 326.69 |
Financial Efficiency
Return on equity (ROE) is 7.35% and return on invested capital (ROIC) is 8.96%.
| Return on Equity (ROE) | 7.35% |
| Return on Assets (ROA) | 2.29% |
| Return on Invested Capital (ROIC) | 8.96% |
| Return on Capital Employed (ROCE) | 4.32% |
| Weighted Average Cost of Capital (WACC) | 5.07% |
| Revenue Per Employee | 1.09M |
| Profits Per Employee | 146,605 |
| Employee Count | 3,114 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, SHA:603367 has paid 63.76 million in taxes.
| Income Tax | 63.76M |
| Effective Tax Rate | 12.14% |
Stock Price Statistics
The stock price has decreased by -32.27% in the last 52 weeks. The beta is 0.15, so SHA:603367's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -32.27% |
| 50-Day Moving Average | 14.49 |
| 200-Day Moving Average | 15.97 |
| Relative Strength Index (RSI) | 46.11 |
| Average Volume (20 Days) | 10,080,128 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603367 had revenue of CNY 3.40 billion and earned 456.53 million in profits. Earnings per share was 1.00.
| Revenue | 3.40B |
| Gross Profit | 1.71B |
| Operating Income | 283.41M |
| Pretax Income | 525.05M |
| Net Income | 456.53M |
| EBITDA | 495.55M |
| EBIT | 283.41M |
| Earnings Per Share (EPS) | 1.00 |
Balance Sheet
The company has 3.65 billion in cash and 30.41 million in debt, with a net cash position of 3.62 billion or 8.00 per share.
| Cash & Cash Equivalents | 3.65B |
| Total Debt | 30.41M |
| Net Cash | 3.62B |
| Net Cash Per Share | 8.00 |
| Equity (Book Value) | 6.42B |
| Book Value Per Share | 13.84 |
| Working Capital | 4.51B |
Cash Flow
In the last 12 months, operating cash flow was 540.15 million and capital expenditures -29.27 million, giving a free cash flow of 510.88 million.
| Operating Cash Flow | 540.15M |
| Capital Expenditures | -29.27M |
| Depreciation & Amortization | 212.13M |
| Net Borrowing | -647,477 |
| Free Cash Flow | 510.88M |
| FCF Per Share | 1.13 |
Margins
Gross margin is 50.36%, with operating and profit margins of 8.34% and 13.43%.
| Gross Margin | 50.36% |
| Operating Margin | 8.34% |
| Pretax Margin | 15.45% |
| Profit Margin | 13.43% |
| EBITDA Margin | 14.58% |
| EBIT Margin | 8.34% |
| FCF Margin | 15.03% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | -20.91% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 34.12% |
| Buyback Yield | -0.55% |
| Shareholder Yield | 1.63% |
| Earnings Yield | 7.06% |
| FCF Yield | 7.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |